Device Trial Radar · NCT01930916
Accuracy of a Portable International Normalized Ratio Monitor in Elderly Patients
Last checked: Nov 19, 2026Latest source record: Apr 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Oct 2012
Primary completion
Nov 2014
Study completion Dec 2014
Sponsor
- Lead sponsor
- University Hospital, CaenAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Aug 29, 2013
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Who can join
- All sexes, from 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Oral anticoagulants vitamin K antagonists (VKA) have been used for many years in the treatment of thromboembolic disorders, which are among the most costly diseases in terms of public health resources. According to the Agence française de sécurité sanitaire des produits de santé (AFSSAPS), it was estimated at about 900,000 the number of patients treated with VKA in 2008 (more than 1% of the French population). VKA are at the origin of many adverse effects, given their narrow therapeutic window. They are the cause of the death of approximately 5000 patients per year. The use of this therapy is a priority axis of reflection for the Haute Autorité de Santé. The interregion G4 (Nord Pas de Calais, Normandy, Picardy), with more than 9 million people, is particularly affected by this problem. University hospitals of our interregion, given their very substantial regional referral activity, are actually involved in managing VKA adverse side effects. Elderly population constitutes the majority of prescriptions. The main objective of this study is to compare INR of people older than 75 years measured by traditional method with those measured by capillary method with INRatio2 supply. The secondary objective is to show that this measure is not affected by the presence or absence of anti-phospholipid antibodies, probably very prevalent in the elderly, as well as to test the variability of INR measurement between different hospital.
Conditions
- Blood Coagulation Disorders
- Blood Coagulation Disorder With Prolonged Bleeding Time
- Blood Coagulation Disorder With Prolonged Coagulation Time
Interventions
INR capillary measurement with INRatio 2 deviceDevice
INR capillary measurement with INRatio 2 device
antiphospholipid antibodies and lupus anticoagulantOther
Rate of antiphospholipid antibodies and lupus anticoagulant dosage A 5ml blood sample obtained by veinous punction.
Primary outcomes
What the sponsor says the trial is designed to measure.
- INR by capillary method and INR by veinous punctionTime frame: 24 hours
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Centre hospitalier régional universitaire d'Amiens
Amiens, France · Not yet recruiting
Centre hospitalier régional universitaire de Caen
Caen, France · Recruiting
Centre hospitalier régional universitaire de Lille
Lille, France · Not yet recruiting
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.